Form 4: Outset Medical CEO Sells Shares for Tax Obligations

Outset Medical CEO Leslie Trigg sold 13,914 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Leslie Trigg, Chair and CEO of Outset Medical, Inc. (OM), reported the sale of common stock.
• A total of 13,914 shares were sold across two transactions on January 20, 2026, and January 21, 2026.
• The shares were sold at prices of $5.12 and $5.05 per share, respectively.
• The sales were non-discretionary, executed as a "sell to cover" to satisfy partial tax withholding obligations.
• These tax obligations arose from the vesting of 32,552 Restricted Stock Units (RSUs) that were granted to Leslie Trigg on June 10, 2025.
• Following these transactions, Leslie Trigg directly owns 105,703 shares of common stock.
• Additionally, Leslie Trigg indirectly owns 41,666 shares through the Trigg 2002 Rev Trust and 584 shares through the Trigg Family Trust, totaling 42,250 indirect shares.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary "sell to cover" to satisfy tax obligations from RSU vesting, which is a standard compensation event and does not reflect a change in management's outlook or a discretionary sale. Therefore, the sentiment is neutral.

Positives

• The vesting of 32,552 Restricted Stock Units (RSUs) indicates a significant compensation event for the CEO, reflecting performance or tenure.

Future Outlook

NA

Management Comments

• The sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale represents a routine, non-discretionary transaction by a key executive, unlikely to have a significant impact on the company's share price or investor sentiment. The underlying RSU vesting is a form of executive compensation.

Key Dates

Recommendation

This Form 4 reports a routine "sell to cover" transaction by the CEO to satisfy tax obligations related to RSU vesting. Such non-discretionary sales are common and do not typically signal a change in management's confidence or the company's fundamentals. Therefore, it does not provide a basis for altering an existing investment recommendation.

Keywords

Outset Medical, OM, Leslie Trigg, Form 4, Insider Transaction, Stock Sale, RSU, Restricted Stock Units, Tax Withholding, CEO, Director